BRIEF-EMA's PRAC Finds No Causal Association Between GLP-1 Drugs And Suicidal And Self-Injurious Thoughts And Actions

EMA: * EMA'S PRAC: GLP-1 RECEPTOR AGONISTS: AVAILABLE EVIDENCE NOT SUPPORTING LINK WITH SUICIDAL AND SELF-INJURIOUS THOUGHTS AND ACTIONS

* EMA SAYS PRAC STUDY FOUND NO CAUSAL ASSOCIATION BETWEEN THE USE OF SEMAGLUTIDE AND SUICIDAL THOUGHTS * EMA'S PRAC: NO CAUSAL ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONISTS & RISK OF SUICIDE-RELATED EVENTS IN PEOPLE WITH TYPE 2 DIABETES MELLITUS

* EMA'S PRAC: AGREED CONTENT OF THE DHPC WILL BE FORWARDED TO THE CHMP FOR ADOPTION FOR NEW RYBELSUS TABLETS (ORAL SEMAGLUTIDE) Source text for Eikon:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)